Amgen Inc. (AMGN) Stock: Revenue, Earnings, Margins & Valuation
Amgen Inc. (AMGN), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Amgen Inc. key figures (FY 2025)
| Revenue | 36.75 USD bn |
|---|---|
| Gross profit | 24.71 USD bn |
| Operating income | 9.08 USD bn |
| Net income | 7.71 USD bn |
| Net margin | 21.0 % |
Amgen Inc. revenue by segment
| U.S. product sales | 25.66 USD bn |
|---|---|
| Rest of world product sales | 9.49 USD bn |
| Other revenues | 1.60 USD bn |
Amgen Inc. business model
The income statement of Amgen Inc. is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.